Marker Therapeutics (MRKR) Other Operating Expenses (2010 - 2025)
Marker Therapeutics (MRKR) reported Other Operating Expenses of $453135.0 for Q1 2025, down 99.61% quarter-over-quarter from $116.0 million in Q4 2018.
Marker Therapeutics (MRKR) Other Operating Expenses (2010 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has 7 years of Other Operating Expenses data on file, last reported at $453135.0 in Q1 2025.
- Other Operating Expenses for Q1 2025 came in at $453135.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $453135.0 (changed N/A YoY), and the FY2025 annual result was $453135.0, changed N/A from the prior year.
- Other Operating Expenses slipped to $453135.0 in Q1 2025 per MRKR's latest filing, from $116.0 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $453135.0 in Q1 2025 and troughed at $453135.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 453,135.00 |
| Dec 31, 2018 | 116.04 Mn |
| Sep 30, 2014 | -94,640.00 |
| Jun 30, 2014 | 920,233.00 |
| Sep 30, 2013 | 212,823.00 |
| Jun 30, 2013 | 532,619.00 |
| Mar 31, 2013 | 699,023.00 |
| Dec 31, 2012 | 857,192.00 |
| Sep 30, 2012 | 457,390.00 |
| Jun 30, 2012 | 2.42 Mn |
| Mar 31, 2012 | 414,426.00 |
| Dec 31, 2011 | 572,980.00 |
| Sep 30, 2011 | 583,060.00 |
| Jun 30, 2011 | 606,900.00 |
| Mar 31, 2011 | 1.04 Mn |
| Dec 31, 2010 | 1.22 Mn |
| Sep 30, 2010 | 1.11 Mn |
| Jun 30, 2010 | 1.08 Mn |